CD4 and non-small cell lung carcinoma: Immune profiling studies on non-small cell lung cancer (NSCLC), renal cancer and melanoma PDOs demonstrated retention of CD8+ and CD4 + T cells, CD14/CD69+ macrophages, NK and NKT cells and B cells [74].